Short Interest in PAVmed Inc. (NASDAQ:PAVM) Rises By 161.8%

PAVmed Inc. (NASDAQ:PAVM) saw a significant increase in short interest in the month of January. As of January 30th, there was short interest totaling 129,582 shares, an increase of 161.8% from the January 15th total of 49,495 shares. Based on an average trading volume of 5,566,555 shares, the days-to-cover ratio is presently 0.0 days. Currently, 14.5% of the shares of the stock are short sold. Currently, 14.5% of the shares of the stock are short sold. Based on an average trading volume of 5,566,555 shares, the days-to-cover ratio is presently 0.0 days.

Analyst Ratings Changes

A number of brokerages have recently issued reports on PAVM. Ascendiant Capital Markets cut their price target on shares of PAVmed from $600.00 to $510.00 and set a “buy” rating for the company in a report on Wednesday, December 10th. Zacks Research downgraded shares of PAVmed from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 24th. Finally, Weiss Ratings restated a “sell (d)” rating on shares of PAVmed in a report on Thursday, January 22nd. One research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, PAVmed presently has a consensus rating of “Hold” and a consensus target price of $510.00.

PAVmed Stock Down 5.2%

Shares of PAVM stock traded down $0.54 during mid-day trading on Thursday, hitting $9.92. 28,842 shares of the company’s stock were exchanged, compared to its average volume of 2,115,661. The stock has a market cap of $9.72 million, a price-to-earnings ratio of -0.58 and a beta of 1.12. The stock has a 50-day simple moving average of $8.95 and a two-hundred day simple moving average of $11.63. PAVmed has a fifty-two week low of $6.00 and a fifty-two week high of $28.44.

Institutional Trading of PAVmed

An institutional investor recently raised its position in PAVmed stock. Jane Street Group LLC increased its position in PAVmed Inc. (NASDAQ:PAVM) by 392.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 52,676 shares of the company’s stock after buying an additional 41,990 shares during the quarter. Jane Street Group LLC owned about 0.31% of PAVmed worth $32,000 as of its most recent filing with the Securities and Exchange Commission. Institutional investors own 19.93% of the company’s stock.

About PAVmed

PAVmed Inc is a clinical-stage medical technology company focused on acquiring, developing and commercializing innovative medical devices aimed primarily at gastrointestinal endoscopy and related therapeutic areas. Its portfolio includes FDA-cleared products such as EsoFLIP® Distensibility System for the treatment of esophageal strictures and MUSE™ (Medigus Ultrasonic Surgical Endostapler) for endoscopic fundoplication in gastroesophageal reflux disease (GERD). In addition to its gastrointestinal franchise, PAVmed is advancing early-stage programs targeting indications in oncology, urology and dermatology.

Founded in 2012, PAVmed has built its pipeline through internal research and development as well as strategic collaborations and acquisitions.